These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3139419)

  • 1. Clinical applications of heparin-binding growth factors.
    Lobb RR
    Eur J Clin Invest; 1988 Aug; 18(4):321-36. PubMed ID: 3139419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.
    Hubka KM; Carson DD; Harrington DA; Farach-Carson MC
    Acta Biomater; 2019 Oct; 97():385-398. PubMed ID: 31351252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts in tissue repair: skin as an example.
    Meddahi A; Caruelle JP; Gold L; Rosso Y; Barritault D
    Diabetes Metab; 1996 Jul; 22(4):274-8. PubMed ID: 8767175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of heparin-binding endothelial cell growth factors.
    Lobb R; Sasse J; Sullivan R; Shing Y; D'Amore P; Jacobs J; Klagsbrun M
    J Biol Chem; 1986 Feb; 261(4):1924-8. PubMed ID: 3003088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of class 1 and class 2 heparin-binding growth factors on protein synthesis and actin mRNA expression in BALB/c-3T3 cells.
    Rybak SM; Lobb RR; Fett JW
    J Cell Physiol; 1988 Aug; 136(2):312-8. PubMed ID: 2457594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
    Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA
    J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of heparin-binding growth factors.
    Lobb RR; Harper JW; Fett JW
    Anal Biochem; 1986 Apr; 154(1):1-14. PubMed ID: 3518534
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis.
    Burgess WH; Shaheen AM; Hampton B; Donohue PJ; Winkles JA
    J Cell Biochem; 1991 Feb; 45(2):131-8. PubMed ID: 1711526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor).
    Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat.
    Rosengart TK; Kuperschmid JP; Maciag T; Clark RE
    Circ Res; 1989 Feb; 64(2):227-34. PubMed ID: 2463884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro.
    Rosengart TK; Johnson WV; Friesel R; Clark R; Maciag T
    Biochem Biophys Res Commun; 1988 Apr; 152(1):432-40. PubMed ID: 2451918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFs and their receptors, in vitro and in vivo studies: new FGF receptor in the brain, FGF-1 in muscle, and the use of functional analogues of low-affinity heparin-binding growth factor receptors in tissue repair.
    Soulet L; Chevet E; Lemaitre G; Blanquaert F; Meddahi A; Barritault D
    Mol Reprod Dev; 1994 Sep; 39(1):49-54; discussion 54-5. PubMed ID: 7528027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.
    Savorè C; Zhang C; Muir C; Liu R; Wyrwa J; Shu J; Zhau HE; Chung LW; Carson DD; Farach-Carson MC
    Clin Exp Metastasis; 2005; 22(5):377-90. PubMed ID: 16283481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro.
    Rouet V; Meddahi-Pellé A; Miao HQ; Vlodavsky I; Caruelle JP; Barritault D
    J Biomed Mater Res A; 2006 Sep; 78(4):792-7. PubMed ID: 16741978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Ca2(+)-dependent intercellular adhesion in bovine aortic and human umbilical vein endothelial cells by heparin-binding growth factors.
    Bavisotto LM; Schwartz SM; Heimark RL
    J Cell Physiol; 1990 Apr; 143(1):39-51. PubMed ID: 2318909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester reduces number of heparin-binding growth-factor receptors in human adult endothelial cells.
    Hoshi H; Kan M; Mioh H; Chen JK; McKeehan WL
    FASEB J; 1988 Sep; 2(12):2797-800. PubMed ID: 2457532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor.
    Lobb RR; Alderman EM; Fett JW
    Biochemistry; 1985 Sep; 24(19):4969-73. PubMed ID: 2416338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration.
    Joung YK; Bae JW; Park KD
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1173-84. PubMed ID: 18976129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo.
    Rosengart TK; Kupferschmid JP; Ferrans VJ; Casscells W; Maciag T; Clark RE
    J Vasc Surg; 1988 Feb; 7(2):311-7. PubMed ID: 2448501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to tissue regeneration and repair.
    Meddahi A; Blanquaert F; Saffar JL; Colombier ML; Caruelle JP; Josefonvicz J; Barritault D
    Pathol Res Pract; 1994 Oct; 190(9-10):923-8. PubMed ID: 7534914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.